Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups

To study how breast cancer cell lines with different FV expression and p53 mutation status responded to increasing concentrations of doxorubicin on cell growth, the p53 mutant cell

5.2.1 BRCA1 and TP53 related response to cytostatic treatment in breast cancer cells Investigation of breast cancer cell line response to the cytostatic drug Doxorubicin revealed a

- Exploring the possibility of an estrogen-regulated transcriptional control of STAMP1 in breast cancer, using qPCR to assess STAMP1 mRNA levels in

Differential expression reveals novel breast-cancer associated miRNA We performed a differential expression analysis comparing clinically relevant subgroups of breast cancer.

Study the genome-wide expression of miRNAs in HER2+ breast cancer cell lines in relation to Trastuzumab response by searching for differentially expressed genes

Vascular Invasion Signature score shows a correlation to the VEGF signature, wound response signature, NF-Kb related genes, hypoxia gene signature, BMI-1 signature and Oncotype

SIM2-s is expressed in benign breast tissue and has been found to be downregulated in breast cancer derived cell lines and in human breast cancer samples, and linked to

The aim of this study was to establish whether perivascular fibulin-2 expression is associ- ated with patient prognosis in breast cancer, and to see whether this expression pattern